drugset / Trial / NCT01737424
Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the safety, tolerability and pharmacokinetic characteristics of LC28-0126 in healthy male subjects
Timeline
- Start
- 2012-12
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LC28-0126 | Unknown | — | Intravenous |
Indications
No indication recorded.